Abstract:BackgroundBicarbonate (HCO 3 -) is a key indicator of anion excess or deficit and important clinically for assessing acid-base balance. For patient care, HCO 3 - may be reported as a calculated value from blood gas analysis or measured on automated chemistry analyzers. When measured, the final result includes HCO 3 -, carbonate (CO 3 2- ) and carbamino compounds and thus is reported as total CO2 (TCO 2 ). Anecdotally, some patients have discrepancies between HCO 3 - and TCO 2 . However, there is limited data in the published literature assessing agreement between the two methods. Our study aims to compare the calculated HCO 3 - values with measured TCO 2 obtained from simultaneously collected clinical specimens.MethodsThis study included all results from physician ordered HCO 3 - and TCO 2 between 01/2019 to 12/2020 retrospectively retrieved from the laboratory information system (Cerner). Specimens were collected by nursing staff within 5 minutes of each other. TCO 2 was assessed on a Roche cobas 702 (CV = 4.2%) according to the manufacturer's instructions using an enzymatic phosphoenolpyruvate carboxylase method in lithium heparin tubes. HCO 3 - was calculated using a Radiometer ABL800 blood gas analyzer from arterial or venous blood gas samples according to the manufacturer's instructions. Briefly, HCO 3 - is calculated using the Henderson-hasselbalch equation and the measurement of PCO 2 (CV= 1.75%), and pH (CV = 0.06%). Deming regression was performed. The CLIA total allowable error of 4 mmol/L and a reference change value (RCV, Cv Individual = 4%) of -13 and + 14 for TCO 2 was used to assess agreement. All data was analyzed in R.ResultsThere were 101,895 paired HCO 3 - and TCO 2 results during the study period. The values ranged from 4 to 56 mmol/L and the mean was 25.7. The mean difference between the calculated HCO 3 - and measured TCO 2 was 1.33 mmol/L. Relative to HCO 3 -, there were 2,119 (2.1%) TCO 2 results with a negative bias exceeding 4 mmol/L and 427 (0.4%)[FC1] with a positive bias exceeding 4 mmol/L. Twenty-two samples exceeded the positive RCV of 14% and 22 samples exceeded the negative RCV. Deming regression revealed a slope of 1.09 (95% CI: 1.087-1.092) an intercept of -2.19 (-2.18 to -2.06), and a Pearson correlation of 0.960 (0.959 to 0.960). We also analyzed differences between HCO 3 - and TCO 2 in arterial and venous samples. The Pearson r for venous samples was 0.956 (0.955 to 0.957) and for arterial samples was 0.966 (0.966-0.966). Deming regression revealed a slope of 1.099 (0.195 to 1.104) and 1.071 (1.068 to 1.074) for venous and arterial samples respectively. The intercept for venous samples was -1.441 (-1.559 to -1.324) and for arterial was -2.005 (-2.072 to -1.938).ConclusionsThere is bias between HCO 3 - calculations and TCO 2 measurements in simultaneously drawn samples. A small proportion of samples (2.5%) exceed the CLIA total allowable error between the results but very few exceed the RCV. This may due to differences in matrices, with different correlations and slopes observed between arterial and venous specimens. Further studies are required to distinguish the causes of the observed differences between HCO 3 - and TCO 2 .

Comparative analysis of hemoglobin, potassium, sodium, and glucose in arterial blood gas and venous blood of patients with COPD

Arterial blood gas analysis or venous blood gas analysis for adult hospitalised patients with respiratory presentations: a systematic review

[Clinical Application of a Software for the Analysis of Arterial Blood Gases Graph in 231 Patients with Chronic Obstructive Pulmonary Disease].

[Correlation Between the Area of Arterial Blood Gases Graph and the Acid-Base Disturbance in 92 Cases with Chronic Obstructive Pulmonary Disease].

Correlation of Venous Blood Gas and Pulse Oximetry With Arterial Blood Gas in the Undifferentiated Critically Ill Patient

Venous blood gases in the assessment of respiratory failure in patients undergoing sleep studies: a randomized study

A CROSS-SECTIONAL STUDY TO ASSESS THE ASSOCIATION OF VENOUS AND ARTERIAL BLOOD GASES (PH, PCO2 AND HCO3) IN COPD PATIENTS

Comparison of Sodium and Potassium by Point-of-Care Arterial Blood Gas Analyzer and Venous Serum by Central Laboratory Analyser in Emergency Clinical Decision Making

Peripheral venous blood gas analysis: An alternative to arterial blood gas analysis for initial assessment and resuscitation in emergency and intensive care unit patients

Comparison of the Arterial PaCO 2 Values and ETCO 2 Values Measured with Sidestream Capnography in Patients with a Prediagnosis of COPD Exacerbation

Prediction of arterial blood gas values from venous blood gas values in patients with acute respiratory failure receiving mechanical ventilation.

Arterial blood gas analysis and dyselectrolytemia in acute exacerbation of COPD as a prognostic marker

Assessing the Role of Blood Gas Analysis in COVID-19 Patients for Early Warning and Clinical Guidance

Prognostic Value Of Venous Blood Gas Analysis In Patients With Diabetic Ketoacidosis

[Application of capnography and SpO2 measurement in the evaluation of respiratory failure in patients with chronic obstructive pulmonary disease]

B-029 Comparison of Electrolyte Measurement Using Laboratory Autoanalyzer and Blood Gas Analyzer

The Modifications of Arterial Blood Gases Graph and Their Clinical Significance in Patients with Asthma Exacerbation

The effects of hypotension on differences between the results of simultaneous venous and arterial blood gas analysis

Correlation between Carboxyhemoglobin Levels Measured by Blood Gas Analysis and by Multiwave Pulse Oximetry

Increased Blood Glycohemoglobin A1c Levels Lead to Overestimation of Arterial Oxygen Saturation by Pulse Oximetry in Patients with Type 2 Diabetes

A-333 Comparison between measured total carbon dioxide and calculated bicarbonate in hospitalized patients